Your browser doesn't support javascript.
loading
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.
Sipponen, Taina; Af Björkesten, Clas-Göran; Hallinen, Taru; Ilus, Tuire; Soini, Erkki; Eberl, Anja; Heikura, Mikko; Kellokumpu, Mikko; Koskela, Ritva; Nielsen, Christian; Nuutinen, Heikki; Heikkinen, Markku; Suhonen, Ulla-Maija; Tillonen, Jyrki; Wennerström, E Christina M; Borsi, Andras; Koivunen, Minni R.
Afiliación
  • Sipponen T; Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Af Björkesten CG; Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Hallinen T; ESiOR Oy, Kuopio, Finland.
  • Ilus T; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
  • Soini E; ESiOR Oy, Kuopio, Finland.
  • Eberl A; Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Heikura M; Department of Gastroenterology, North Karelia Central Hospital, Joensuu, Finland.
  • Kellokumpu M; Department of Internal Medicine, Lapland Central Hospital, Rovaniemi, Finland.
  • Koskela R; Department of Medicine, Division of Gastroenterology, Oulu University Hospital, Oulu, Finland.
  • Nielsen C; Department of Internal Medicine, Vaasa Central Hospital, Vaasa, Finland.
  • Nuutinen H; Division of Gastroenterology, Department of Medicine, Turku University Hospital, Turku, Finland.
  • Heikkinen M; Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland.
  • Suhonen UM; Department of Internal Medicine, Kainuu Central Hospital, Kajaani, Finland.
  • Tillonen J; Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
  • Wennerström ECM; Medical Affairs, Janssen Cilag AB, Solna, Sweden.
  • Borsi A; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Koivunen MR; Janssen Cilag Limited, EMEA HEMAR, High Wycombe, United Kingdom.
Scand J Gastroenterol ; 56(6): 661-670, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33820465
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Scand J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Scand J Gastroenterol Año: 2021 Tipo del documento: Article País de afiliación: Finlandia